(Q51995396)

19 April 2018

title

Expression and regulation of the chemokine receptor CXCR3 on lymphocytes from normal and inflammatory bowel disease mucosa. (English)

1 reference

19 April 2018

inflammatory bowel diseases

main subject

1 reference

7

Stephan R Targan

1 reference

19 April 2018

author name string

Konstantinos A Papadakis

1

1 reference

19 April 2018

John Prehn

2

1 reference

19 April 2018

Daocheng Zhu

3

1 reference

19 April 2018

Carol Landers

4

1 reference

19 April 2018

Joanne Gaiennie

5

1 reference

19 April 2018

Phillip R Fleshner

6

1 reference

19 April 2018

publication date

1 November 2004

1 reference

19 April 2018

Inflammatory Bowel Diseases

published in

1 reference

19 April 2018

volume

10

1 reference

19 April 2018

issue

6

1 reference

19 April 2018

page(s)

778-788

1 reference

19 April 2018

Chemokines and leukocyte traffic

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Chemokines--chemotactic cytokines that mediate inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Chemokine receptor CXCR3 expression in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Inflammatory bowel disease: etiology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Current theories on the causes of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

Structure-function relationship between the human chemokine receptor CXCR3 and its ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

CCR5 is characteristic of Th1 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00013

10.1097/00054725-200411000-00013

21 January 2018

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018